⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium SCHEMBL30174048 | 1.00 | — | — | |
| Lithium SCHEMBL4681973 | 1.00 | — | — | |
| Lithium SCHEMBL2942725 | 1.00 | — | — | |
| Lithium SCHEMBL7300085 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL29805250 | 0.82 | — | — | |
| Phosphine SCHEMBL16175816 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL135454 | 0.82 | — | — | |
| Fluoride SCHEMBL9052068 | 0.82 | — | — | |
| SCHEMBL17931018 | 0.71 | — | — | |
| SCHEMBL188 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743400-A1 | GROUP 14 - GROUP 1 CATHODE | Group14 Technologies, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20250340447-A1 | NOVEL METAL-SILICON ALLOY-CARBON COMPOSITE, ELECTRODES, AND DEVICE | GROUP14 TECHNOLOGIES INC (US) | 2025-11-06 | — | — | US | disclosed |
| WO-2025111550-A1 | LITHIUM-CARBON BATTERY MATERIALS PRODUCED VIA PLASMA PYROLYSIS | GROUP14 TECHNOLOGIES, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| US-20250136533-A1 | LITHIUM CARBIDE MATERIAL | GROUP14 TECHNOLOGIES, INC. | 2025-05-01 | — | — | US | disclosed |
| US-20250030000-A1 | LITHIUM CARBON COMPOSITE BATTERY | GROUP14 TECHNOLOGIES, INC. | 2025-01-23 | — | — | US | disclosed |
| WO-2025015304-A1 | GROUP 14 - GROUP 1 CATHODE | GROUP14 TECHNOLOGIES, INC. (US) | 2025-01-16 | — | — | WO | disclosed |
| EP-4434099-A1 | LITHIUM CARBON COMPOSITE BATTERY | Group14 Technologies, Inc. (US) | 2024-09-25 | — | — | EP | disclosed |
| CN-118302870-A | Lithium-carbon composite battery | 14集团技术公司 | 2024-07-05 | — | — | CN | disclosed |
| WO-2023215232-A9 | NOVEL METAL-SILICON ALLOY-CARBON COMPOSITE, ELECTRODES, AND DEVICE | GROUP14 TECHNOLOGIES, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023092030-A9 | LITHIUM CARBON COMPOSITE BATTERY | GROUP14 TECHNOLOGIES, INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| EP-2536410-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS | Merck Sharp & Dohme Corp. (US) | 2012-12-26 | — | — | EP | disclosed |
| US-20110318305-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS | MERCK SHARP & DOHME LLC | 2011-12-29 | — | — | US | disclosed |
| WO-2011130613-A1 | TARGETED PYRROLOBENZODIAZAPINE CONJUGATES | SEATTLE GENETICS, INC. (US) | 2011-10-20 | — | — | WO | disclosed |
| WO-2011130616-A1 | PYRROLOBENZODIAZEPINES USED TO TREAT PROLIFERATIVE DISEASES | SPIROGEN LIMITED (GB) | 2011-10-20 | — | — | WO | disclosed |
| WO-2011103441-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS | SCHERING CORPORATION (US) | 2011-08-25 | — | — | WO | disclosed |
| US-20110196148-A1 | UNSYMMETRICAL PYRROLOBENZODIAZEPINE-DIMERS FOR TREATMENT OF PROLIFERATIVE DISEASES | SPIROGEN LIMITED (GB) | 2011-08-11 | — | — | US | disclosed |
| EP-2350080-A1 | UNSYMMETRICAL PYRROLOBENZODIAZEPINE-DIMERS FOR TREATMENT OF PROLIFERATIVE DISEASES | Spirogen Limited (GB) | 2011-08-03 | — | — | EP | disclosed |
| EP-2326627-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS | Schering Corporation (US) | 2011-06-01 | — | — | EP | disclosed |
| WO-2010043880-A1 | UNSYMMETRICAL PYRROLOBENZODIAZEPINE-DIMERS FOR TREATMENT OF PROLIFERATIVE DISEASES | SPIROGEN LIMITED (GB) | 2010-04-22 | — | — | WO | disclosed |
| WO-2010022121-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS | SCHERING CORPORATION (US) | 2010-02-25 | — | — | WO | disclosed |